We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-1.65%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.51B
AUM Growth
-$59.4M
Cap. Flow
+$92.2M
Cap. Flow %
6.09%
Top 10 Hldgs %
50.09%
Holding
339
New
32
Increased
81
Reduced
57
Closed
39

Sector Composition

Rank Sector Weight
1 Healthcare 31.82%
2 Financials 5.48%
3 Industrials 3.38%
4 Technology 2.61%
5 Communication Services 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEON icon
101
VEON
VEON
$3.55B
$1.85M 0.12%
26,424
WVE icon
102
Wave Life Sciences
WVE
$1.12B
$1.84M 0.12%
70,088
+11,000
+19% +$308K
CL icon
103
Colgate-Palmolive
CL
$76B
$1.81M 0.12%
25,050
+100
+0.4% +$7.1K
DIS icon
104
Walt Disney
DIS
$172B
$1.74M 0.12%
+12,508
New +$1.66M
INFY icon
105
Infosys
INFY
$49.5B
$1.74M 0.11%
163,510
+103,580
+173% +$1.1M
B
106
Barrick Mining
B
$60.9B
$1.73M 0.11%
110,000
+7,000
+7% +$92.9K
AXP icon
107
American Express
AXP
$225B
$1.72M 0.11%
13,855
-500
-3% -$58.7K
BLK icon
108
Blackrock
BLK
$168B
$1.7M 0.11%
3,662
-628
-15% -$284K
QCOM icon
109
Qualcomm
QCOM
$175B
$1.68M 0.11%
22,300
MRK icon
110
Merck
MRK
$332B
$1.65M 0.11%
20,677
-2,620
-11% -$201K
CYTK icon
111
Cytokinetics
CYTK
$10.8B
$1.64M 0.11%
148,353
-91,439
-38% -$882K
NKE icon
112
Nike
NKE
$63.9B
$1.64M 0.11%
19,567
GFI icon
113
Gold Fields
GFI
$28.8B
$1.63M 0.11%
300,000
+200,000
+200% +$854K
PVLA
114
Palvella Therapeutics
PVLA
$2B
$1.62M 0.11%
4,559
+1,775
+64% +$529K
AU icon
115
AngloGold Ashanti
AU
$39.8B
$1.61M 0.11%
90,000
+60,000
+200% +$805K
SLG icon
116
SL Green Realty
SLG
$3.75B
$1.59M 0.11%
20,660
EIGR
117
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.55M 0.1%
4,840
NBRV
118
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.48M 0.1%
2,666
VTRS icon
119
Viatris
VTRS
$20.8B
$1.47M 0.1%
77,500
+4,340
+6% +$96K
KALA icon
120
KALA BIO
KALA
$11.7M
$1.45M 0.1%
99
CTAS icon
121
Cintas
CTAS
$87.2B
$1.41M 0.09%
24,000
TSM icon
122
TSMC
TSM
$1.99T
$1.39M 0.09%
35,120
LLY icon
123
Eli Lilly
LLY
$1.1T
$1.36M 0.09%
12,245
+800
+7% +$94.2K
ADMS
124
DELISTED
Adamas Pharmaceuticals
ADMS
$1.33M 0.09%
223,959
FTS icon
125
Fortis
FTS
$30.2B
$1.32M 0.09%
19,560
+9,230
+89% +$349K

Similar funds

Fosun International's Q2 2019 Portfolio in Review

As of Q2 2019, Fosun International held 339 positions worth $1.51B, down 3.8% from $1.57B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Fosun International deployed $92.2M of net new capital in Q2 2019, opening 32 new positions and adding to 81 existing holdings. Its largest new stake was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was DigitalBridge, an estimated $14.9M trimmed.

  • Fosun International's largest Q2 2019 buy was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
  • Fosun International added most to Array Biopharma Inc in Q2 2019, an estimated $3.22M increase.
  • Fosun International's biggest Q2 2019 reduction was DigitalBridge, cutting an estimated $14.9M.
  • Fosun International fully exited Baozun in Q2 2019, selling an estimated $20.3M.
  • Fosun International's ten largest holdings make up 50% of its $1.51B portfolio in Q2 2019.
  • Fosun International opened 32 new positions and closed 39 in Q2 2019.
  • Fosun International's portfolio value fell 3.8% quarter-over-quarter to $1.51B.

Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.